Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
The International Heart Institute of Montana
mi
from
Missoula, MT
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
The International Heart Institute of Montana
mi
from
Missoula, MT
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Cooper University Hospital
mi
from
Camden, NJ
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Cooper University Hospital
mi
from
Camden, NJ
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
New York Methodist Hospital
mi
from
Brooklyn, NY
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
New York Methodist Hospital
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
The Mount Sinai Hospital
mi
from
New York, NY
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
The Mount Sinai Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
SUNY Stony Brook University Hospital
mi
from
Stony Brook, NY
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
SUNY Stony Brook University Hospital
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
East Carolina University
mi
from
Greenville, NC
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Cleveland Clinic
mi
from
Cleveland, OH
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
University Hospitals of Cleveland
mi
from
Cleveland, OH
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Baylor College of Medicine
mi
from
Houston, TX
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Providence Regional Medical Center
mi
from
Everett, WA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Providence Regional Medical Center
mi
from
Everett, WA
Click here to add this to my saved trials
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated:  8/8/2012
Swedish Medical Center
mi
from
Seattle, WA
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Rapid Evaluation of Acute Kidney Injury With NGAL in Acutely Ill Patients in the ICU
Status: Enrolling
Updated: 8/8/2012
Swedish Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
Status: Enrolling
Updated:  8/8/2012
WellBound of San Jose
mi
from
San Jose, CA
A Double-Blind, Randomized, Placebo-Controlled Safety Study Evaluating the Effects of Residual Renal Function (RFF) in Patients With End-Stage Renal Disease and Type 2 Diabetes Mellitus on Peritoneal Dialysis
Status: Enrolling
Updated: 8/8/2012
WellBound of San Jose
mi
from
San Jose, CA
Click here to add this to my saved trials
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Status: Enrolling
Updated:  8/21/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Status: Enrolling
Updated: 8/21/2012
Clinical Research Facility
mi
from
Santa Clara, CA
Click here to add this to my saved trials
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Status: Enrolling
Updated:  8/21/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Study of FG-4592 to Correct Anemia in New Dialysis Patients
Status: Enrolling
Updated: 8/21/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Does Nesiritide Provide Renal Protection
Does Nesiritide Provide Renal Protection By Attenuating the Inflammatory Response
Status: Enrolling
Updated:  8/28/2012
University of Florida
mi
from
Gainesville, FL
Does Nesiritide Provide Renal Protection
Does Nesiritide Provide Renal Protection By Attenuating the Inflammatory Response
Status: Enrolling
Updated: 8/28/2012
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
Status: Enrolling
Updated:  8/29/2012
Creighton University
mi
from
Omaha, NE
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
Pharmacokinetic Comparison of Vitamin's D2 and D3 in Stage 5 Chronic Kidney Disease Patients on Chronic Hemodialysis
Status: Enrolling
Updated: 8/29/2012
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
A Phase I, Single Dose, Parallel-Group Study To Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
Status: Enrolling
Updated:  9/6/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
A Phase I, Single Dose, Parallel-Group Study To Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
Status: Enrolling
Updated: 9/6/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
A Phase I, Single Dose, Parallel-Group Study To Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
Status: Enrolling
Updated:  9/6/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
A Phase I, Single Dose, Parallel-Group Study To Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
Status: Enrolling
Updated: 9/6/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
A Phase I, Single Dose, Parallel-Group Study To Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
Status: Enrolling
Updated:  9/6/2012
Pfizer Investigational Site
mi
from
Duluth, MN
A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
A Phase I, Single Dose, Parallel-Group Study To Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function
Status: Enrolling
Updated: 9/6/2012
Pfizer Investigational Site
mi
from
Duluth, MN
Click here to add this to my saved trials
The Effects of Continuous Transversus Abdominis Plane (TAP) Catheters on Postoperative Pain After Renal Transplantation
Status: Enrolling
Updated:  9/7/2012
Cleveland Clinic
mi
from
Cleveland, OH
The Effects of Continuous Transversus Abdominis Plane (TAP) Catheters on Postoperative Pain After Renal Transplantation
Status: Enrolling
Updated: 9/7/2012
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)
Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Colcrys (Colchicine, USP) Tablets 0.6 mg Administered to Healthy Subjects and Subjects With Mild, Moderate, Severe Renal Impairment, and End-Stage Renal Disease
Status: Enrolling
Updated:  9/11/2012
West Coast Clinical Trials, LLC
mi
from
Cypress, CA
Healthy and Renal Impairment Study of Colcrys (Colchicine, USP)
Single-Dose, Open-Label Study of the Pharmacokinetics, Safety, and Tolerability of Colcrys (Colchicine, USP) Tablets 0.6 mg Administered to Healthy Subjects and Subjects With Mild, Moderate, Severe Renal Impairment, and End-Stage Renal Disease
Status: Enrolling
Updated: 9/11/2012
West Coast Clinical Trials, LLC
mi
from
Cypress, CA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated:  9/11/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated: 9/11/2012
Pfizer Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated:  9/11/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated: 9/11/2012
Pfizer Investigational Site
mi
from
Atlantis, FL
Click here to add this to my saved trials
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated:  9/11/2012
Pfizer Investigational Site
mi
from
Detroit, MI
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated: 9/11/2012
Pfizer Investigational Site
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated:  9/11/2012
Pfizer Investigational Site
mi
from
Duluth, MN
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated: 9/11/2012
Pfizer Investigational Site
mi
from
Duluth, MN
Click here to add this to my saved trials
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated:  9/11/2012
Pfizer Investigational Site
mi
from
Rochester, NY
A Study To Evaluate The Safety And Tolerability Of PF-03882845 In Patients With Type 2 Diabetic Nephropathy
A 2-week, Phase 1b, Randomized, Double-Blind, Placebo- Controlled, Multi-Dose, Dose-Escalating Study With PF-03882845 And One Dose Of Spironolactone To Evaluate Safety, Tolerability, Pharmacokinetics And Pharmacodynamics In Subjects With Type 2 Diabetes Mellitus And Albuminuria
Status: Enrolling
Updated: 9/11/2012
Pfizer Investigational Site
mi
from
Rochester, NY
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Nephrology Associates, P.C.
mi
from
Birmingham, AL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Nephrology Associates, P.C.
mi
from
Birmingham, AL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
AKDHC Sun City Nephrology
mi
from
Peoria, AZ
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
AKDHC Sun City Nephrology
mi
from
Peoria, AZ
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
AKDHC Medical Research Services, LLC
mi
from
Phoenix, AZ
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
AKDHC Medical Research Services, LLC
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
AKDHC Central Nephrology
mi
from
Phoenix, AZ
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
AKDHC Central Nephrology
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
AKDHC Medical Research Greenway Office
mi
from
Phoenix, AZ
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
AKDHC Medical Research Greenway Office
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Southwest Clinical Research Institute
mi
from
Tempe, AZ
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Southern Arizona VA Healthcare System
mi
from
Tucson, AZ
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Southern Arizona VA Healthcare System
mi
from
Tucson, AZ
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Fayetteville Diagnostic Clinic, Ltd
mi
from
Fayetteville, AR
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Fayetteville Diagnostic Clinic, Ltd
mi
from
Fayetteville, AR
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
California Institute of Renal Research
mi
from
La Mesa, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
California Institute of Renal Research
mi
from
La Mesa, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Clinical Trials of St. Jude Heritage Medical Group
mi
from
Fullerton, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Clinical Trials of St. Jude Heritage Medical Group
mi
from
Fullerton, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Marin Endocrine Care & Research Associates
mi
from
Greenbrae, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Marin Endocrine Care & Research Associates
mi
from
Greenbrae, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Scripps Clinic
mi
from
La Jolla, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Scripps Clinic
mi
from
La Jolla, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Tower Nephrology Medical Group
mi
from
Los Angeles, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Tower Nephrology Medical Group
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Academic Medical Research Institute
mi
from
Los Angeles, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Academic Medical Research Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
DaVita - Century City
mi
from
Los Angeles, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
DaVita - Century City
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
University of Southern California
mi
from
Los Angeles, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
Richard Cherlin, MD
mi
from
Los Gatos, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
Richard Cherlin, MD
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
La Jolla Clinical Research, Inc
mi
from
Chula Vista, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
La Jolla Clinical Research, Inc
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated:  9/14/2012
The Endocrine Medical Group, Inc.
mi
from
Orange, CA
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes
Bardoxolone Methyl Evaluation in Patients With Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)
Status: Enrolling
Updated: 9/14/2012
The Endocrine Medical Group, Inc.
mi
from
Orange, CA
Click here to add this to my saved trials